Literature DB >> 12130497

Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.

David A Hess1, Krysta D Levac, Francis N Karanu, Michael Rosu-Myles, Martin J White, Lisa Gallacher, Barbara Murdoch, Michael Keeney, Pamela Ottowski, Ronan Foley, Ian Chin-Yee, Mickie Bhatia.   

Abstract

Using in vitro progenitor assays, serum-free in vitro cultures, and the nonobese diabetic/severe combined immune-deficient (NOD/SCID) ecotropic murine virus knockout xenotransplantation model to detect human SCID repopulating cells (SRCs) with multilineage reconstituting function, we have characterized and compared purified subpopulations harvested from the peripheral blood (PB) of patients receiving granulocyte colony-stimulating factor (G-CSF) alone or in combination with stem cell factor (SCF). Mobilized G-CSF plus SCF PB showed a 2-fold increase in total mononuclear cell content and a 5-fold increase in CD34-expressing cells depleted for lineage-marker expression (CD34(+)Lin(-)) as compared with patients treated with G-CSF alone. Functionally, G-CSF plus SCF-mobilized CD34(+)CD38(-)Lin(-) cells contained a 2-fold enhancement in progenitor frequency as compared with G-CSF-mobilized subsets. Despite enhanced cellularity and progenitor capacity, G-CSF plus SCF mobilization did not increase the frequency of SRCs as determined by limiting dilution analysis by means of unfractionated PB cells. Purification of SRCs from these sources demonstrated that as few as 1000 CD34(+)CD38(-)Lin(-) cells from G-CSF-mobilized PB contained SRC capacity while G-CSF plus SCF-mobilized CD34(+)CD38(-)Lin(-) cells failed to repopulate at doses up to 500 000 cells. In addition, primitive CD34(-)CD38(-)AC133(+)Lin(-) cells derived from G-CSF plus SCF-mobilized PB were capable of differentiation into CD34-expressing cells, while the identical subfractions from G-CSF PB were unable to produce CD34(+) cells in serum-free cultures. Our study defines qualitative and quantitative distinctions among subsets of primitive cells mobilized by means of G-CSF plus SCF versus G-CSF alone, and therefore has implications for the utility of purified repopulating cells from these sources.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130497     DOI: 10.1182/blood.v100.3.869

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

2.  Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.

Authors:  David A Hess; Jesper Bonde; Timothy P Craft; Timothy C Craft; Louisa Wirthlin; Sarah Hohm; Ryan Lahey; Laura M Todt; John F Dipersio; Steven M Devine; Jan A Nolta
Journal:  Biol Blood Marrow Transplant       Date:  2007-04       Impact factor: 5.742

Review 3.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 4.  Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.

Authors:  Santosh K Sanganalmath; Ahmed Abdel-Latif; Roberto Bolli; Yu-Ting Xuan; Buddhadeb Dawn
Journal:  Basic Res Cardiol       Date:  2011-05-04       Impact factor: 17.165

5.  Turning Death to Growth: Hematopoietic Growth Factors Promote Neurite Outgrowth through MEK/ERK/p53 Pathway.

Authors:  Mei Gao; Li-Ru Zhao
Journal:  Mol Neurobiol       Date:  2017-11-08       Impact factor: 5.590

Review 6.  Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.

Authors:  MirHojjat Khorasanizadeh; Mahsa Eskian; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

7.  Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Authors:  Desislava M Doycheva; Tiffany Hadley; Li Li; Richard L Applegate; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2014-05-27       Impact factor: 5.996

8.  Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Yiming Huang; Adam B Stein; Greg Hunt; Sumit Tiwari; Jai Varma; Yan Gu; Sumanth D Prabhu; Jan Kajstura; Piero Anversa; Suzanne T Ildstad; Roberto Bolli
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

9.  Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.

Authors:  Desislava Doycheva; Gary Shih; Hank Chen; Richard Applegate; John H Zhang; Jiping Tang
Journal:  Transl Stroke Res       Date:  2012-11-08       Impact factor: 6.829

Review 10.  Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed Abdel-Latif; Roberto Bolli; Ewa K Zuba-Surma; Imad M Tleyjeh; Carlton A Hornung; Buddhadeb Dawn
Journal:  Am Heart J       Date:  2008-06-20       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.